- Previous Close
43.29 - Open
43.08 - Bid 41.50 x --
- Ask 41.51 x --
- Day's Range
41.50 - 43.63 - 52 Week Range
20.27 - 54.28 - Volume
2,649,594 - Avg. Volume
3,481,573 - Market Cap (intraday)
8.539B - Beta (5Y Monthly) -0.40
- PE Ratio (TTM)
345.83 - EPS (TTM)
0.12 - Earnings Date --
- Forward Dividend & Yield 0.31 (0.75%)
- Ex-Dividend Date May 17, 2024
- 1y Target Est
--
Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. The company develops paclitaxel polymer micelle for treatment of small cell lung cancer. Shanghai Yizhong Pharmaceutical Co., Ltd. was founded in 2009 and is headquartered in Shanghai, China.
www.yizhongpharma.com304
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 688091.SS
View MorePerformance Overview: 688091.SS
Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688091.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688091.SS
View MoreValuation Measures
Market Cap
8.54B
Enterprise Value
7.90B
Trailing P/E
333.03
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
39.87
Price/Book (mrq)
5.94
Enterprise Value/Revenue
31.50
Enterprise Value/EBITDA
106.01
Financial Highlights
Profitability and Income Statement
Profit Margin
26.17%
Return on Assets (ttm)
2.03%
Return on Equity (ttm)
4.58%
Revenue (ttm)
250.66M
Net Income Avi to Common (ttm)
65.6M
Diluted EPS (ttm)
0.12
Balance Sheet and Cash Flow
Total Cash (mrq)
654.14M
Total Debt/Equity (mrq)
0.76%
Levered Free Cash Flow (ttm)
23.63M